2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Low-value care practice in headache: a Spanish mixed methods research study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Headache is one of the most prevalent diseases. The Global Burden of Disease Study ranks it as the seventh most common disease overall and the second largest neurological cause of disability in the world. The “Do Not Do” recommendations are a strategy for increasing the quality of care and reducing the cost of care for headache. This study aimed to identify specific low-value practices in headache care, determine their frequency, and estimate the cost overrun that they represent, in order to establish “Do not Do” recommendations specifically for headache by consensus and according to scientific evidence.

          Methods

          This was a mixed methods research study that combined qualitative consensus-building techniques, involving a multidisciplinary panel of experts to define the “Do Not Do” recommendations in headache care, and a retrospective observational study with review of a randomized set of patient records from the past 6 months in four hospitals, to quantify the frequency of these “Do Not Do” practices. We calculated the sum of direct costs of medical consultations, medicines, and unnecessary diagnostic tests.

          Results

          Seven “Do Not Do” recommendations were established for headache. In total, 3507 medical records were randomly reviewed. Low-value practices had a highly variable occurrence, depending on the hospital and type of headache. Overall, 34.1% of low-value practices were related to treatment, 21% were related to overuse of imaging in consultation, and 19% were related to emergency care. The estimated cost of low-value practices in the four hospitals was 203,520.47 euros per 1000 patients.

          Conclusions

          This study identified low-value headache practices that need to be eradicated and provided data on their frequency and cost overruns.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: not found

          The cost of headache disorders in Europe: the Eurolight project.

          Headache disorders are very common, but their monetary costs in Europe are unknown. We performed the first comprehensive estimation of how economic resources are lost to headache in Europe.   From November 2008 to August 2009, a cross-sectional survey was conducted in eight countries representing 55% of the adult EU population. Participation rates varied between 11% and 59%. In total, 8412 questionnaires contributed to this analysis. Using bottom-up methodology, we estimated direct (medications, outpatient health care, hospitalization and investigations) and indirect (work absenteeism and reduced productivity at work) annual per-person costs. Prevalence data, simultaneously collected and, for migraine, also derived from a systematic review, were used to impute national costs.   Mean per-person annual costs were €1222 for migraine (95% CI 1055-1389; indirect costs 93%), €303 for tension-type headache (TTH, 95% CI 230-376; indirect costs 92%), €3561 for medication-overuse headache (MOH, 95% CI 2487-4635; indirect costs 92%), and €253 for other headaches (95% CI 99-407; indirect costs 82%). In the EU, the total annual cost of headache amongst adults aged 18-65 years was calculated, according to our prevalence estimates, at €173 billion, apportioned to migraine (€111 billion; 64%), TTH (€21 billion; 12%), MOH (€37 billion; 21%) and other headaches (€3 billion; 2%). Using the 15% systematic review prevalence of migraine, calculated costs were somewhat lower (migraine €50 billion, all headache €112 billion annually).   Headache disorders are prominent health-related drivers of immense economic losses for the EU. This has immediate implications for healthcare policy. Health care for headache can be both improved and cost saving. © 2011 The Author(s). European Journal of Neurology © 2011 EFNS.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Early Trends Among Seven Recommendations From the Choosing Wisely Campaign.

            The Choosing Wisely campaign consists of more than 70 lists produced by specialty societies of medical practices or procedures of minimal clinical benefit to patients in most situations, with recommendations regarding judicious use.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)

              Migraine is a disabling neurological disease that affects 14.7 % of Europeans. Studies evaluating the economic impact of migraine are complex to conduct adequately and with time become outdated as healthcare systems evolve. This study sought to quantify and compare direct medical costs of chronic migraine (CM) and episodic migraine (EM) in five European countries. Cross-sectional data collected via a web-based survey were screened for migraine and classified as CM (≥15 headache days/month) or EM (<15 headache days/month), and included sociodemographics, resource use data and medication use. Unit cost data, gathered using publicly available sources, were analyzed for each type of service, stratified by migraine status. Univariate and multivariate log-normal regression models were used to examine the relationship between various factors and their impact on total healthcare costs. This economic analysis included data from respondents with migraine in the UK, France, Germany, Italy, and Spain. CM participants had higher level of disability and more prevalent psychiatric disorders compared to EM. CM participants had more provider visits, emergency department/hospital visits, and diagnostic tests; the medical costs were three times higher for CM than EM. Per patient annual costs were highest in the UK and Spain and lower in France and Germany. CM was associated with higher medical resource use and total costs compared to EM in all study countries, suggesting that treatments that reduce headache frequency could decrease the clinical and economic burden of migraine in Europe. Comparing patterns of care and outcomes among countries may facilitate the development of more cost-effective care, and bring greater recognition to patients affected by migraine.
                Bookmark

                Author and article information

                Contributors
                jimmy.martind@umh.es
                Journal
                J Headache Pain
                J Headache Pain
                The Journal of Headache and Pain
                Springer Milan (Milan )
                1129-2369
                1129-2377
                10 June 2020
                10 June 2020
                2020
                : 21
                : 1
                : 74
                Affiliations
                [1 ]GRID grid.411083.f, ISNI 0000 0001 0675 8654, Headache Unit, Neurology Department, , Vall d’Hebron Hospital, ; Barcelona, Spain
                [2 ]GRID grid.430994.3, ISNI 0000 0004 1763 0287, Headache and Neurological Pain Research Group, , VHIR, Universitat Autonoma of Barcelona, ; Barcelona, Spain
                [3 ]Albacete General University Hospital, Albacete, Spain
                [4 ]ATENEA research group, Foundation for the Promotion of Health and Biomedical Research, Sant Joan d’Alacant, Spain
                [5 ]GRID grid.411325.0, ISNI 0000 0001 0627 4262, University Hospital Marqués de Valdecilla, ; Santander, Spain
                [6 ]GRID grid.7821.c, ISNI 0000 0004 1770 272X, University of Cantabria and IDIVAL, ; Santander, Spain
                [7 ]Barrio del Pilar Health Center, Madrid, Spain
                [8 ]GRID grid.414761.1, University Hospital Infanta Leonor, ; Madrid, Spain
                [9 ]GRID grid.7759.c, ISNI 0000000103580096, Cádiz University, ; Cádiz, Spain
                [10 ]Patient Safety Observatory, Andalusian Healthcare Quality Agency, Seville, Spain
                [11 ]Health Department Sant Joan d’Alicante, Alicante, Spain
                [12 ]GRID grid.26811.3c, ISNI 0000 0001 0586 4893, Miguel Hernández University of Elche, ; Elche, Spain
                Author information
                http://orcid.org/0000-0003-4384-9197
                Article
                1147
                10.1186/s10194-020-01147-w
                7288523
                32522142
                93f992de-ee68-4867-9fdb-592478bb2750
                © The Author(s) 2020

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 7 April 2020
                : 4 June 2020
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100007819, Allergan;
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2020

                Anesthesiology & Pain management
                care,cost,do not do recommendations,headache,patient safety,mixed methods

                Comments

                Comment on this article